Peconic Partners LLC Crispr Therapeutics Ag Transaction History

Peconic Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $1.05 Million - $1.67 Million	-15,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$110.2 - $156.64 $1.65 Million - $2.35 Million	15,000 New	15,000 $1.68 Million
Q2 2020 Aug 14, 2020	SELL	$38.5 - $76.05 $840,108 - $1.66 Million	-21,821 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$33.68 - $62.53 $1.94 Million - $3.61 Million	-57,704 Reduced 72.56%	21,821 $925,000
Q4 2019 Feb 14, 2020	SELL	$36.68 - $73.13 $2.2 Million - $4.39 Million	-60,000 Reduced 43.0%	79,525 $4.84 Million
Q3 2019 Nov 14, 2019	BUY	$40.99 - $52.56 $5.72 Million - $7.33 Million	139,525 New	139,525 $5.72 Million

493

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.85B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Peconic Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Peconic Partners LLC with notifications on news.